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Abstract 
Although there is a substantial role for social theory in explaining patients’ health behaviors, it does not appear that pharmacists 
commonly use such theories to provide patient care.  This paper attempts to demonstrate an explicit link between social theory and 
pharmacy practice.  The theory of structure and agency and the practice problem of poor medication adherence (MA) in patients with 
HIV/AIDS are used as exemplars to illustrate such a link.  Factors influencing MA were identified from qualitative studies of adherence 
in patients with HIV/AIDS.  All factors identified were stratified into one of four categories: agency related factors that facilitate MA; 
agency related factors that are barriers to MA; structural factors that facilitate MA; structural factors that are barriers to MA.   
Stratifying MA in this manner allows pharmacists to identify clinical interventions that are targeted towards the specific cause of MA 
problems.   
 
 
Introduction 
Pharmacy does not appear to be a profession that sits 
comfortably upon a theoretical foundation.  There are a 
number of practice models described in the literature but 
these are largely descriptions of what pharmacists do.
1-7  
They do not readily serve as conceptual frameworks that 
explain any of the various phenomena (e.g. the component 
parts of recommending a self-care regimen, how they are 
structured and organized and the thought processes behind 
that organization) that constitute the practice of pharmacy.  
They are primarily practice change tools that describe what 
pharmacy may change to (e.g. pharmaceutical care) and how.  
Models describe, while theory explains.  Theory provides a 
base upon which practice change can occur.  As pharmacy 
moves towards a more patient-focused practice, having a 
better understanding of the theoretical underpinnings of 
practice will be necessary. 
 
The most recent American Council on Pharmacy Accreditation 
standards for the professional degree makes numerous 
mentions of the role of the social sciences in pharmacy and 
pharmacy education.
8  However, the term theory appears 
only once in a 97page document, and that single mention 
concerns the role of economic theory in making health care 
resource allocation decisions.  
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Given the prominent role of theory in medical sociology and 
the equally established role of social science in pharmacy 
education and practice, this is, perhaps, surprising.  
Consequently, it may be a useful exercise to explore if there 
are ways to more explicitly tie social theory to practice.  If 
pharmacists have a better understanding of some of the 
theoretical foundations that explain patient behaviors, they 
may be more effective in providing patient counseling and 
other forms of patient care. 
 
Thus, the objective of this paper is to demonstrate that a link 
between theory and pharmacy practice is feasible.  The role 
of the sociological theory of structure and agency in 
promoting medication adherence (MA) will be discussed.  The 
specific practice problem of MA in HIV/AIDS will serve as an 
example of such a link.  Practitioners will find such a link 
helpful to provide more effective patient care because it 
illustrates how patients behave, which in turn gives the 
pharmacist cues for which types of clinical interventions are 
most likely to be successful.  Pharmacy educators will be able 
to use it develop teaching examples for students who will 
then graduate with a better understanding of patient 
behaviors and their effects on practice. 
 
Choosing a Theory - Structure and Agency 
The sheer number, diversity and complexity of theories in the 
social sciences may well lead practitioners to avoid any 
meaningful consideration of social theory.  Thus, selecting a 
theory that pharmacists find both comprehensible and 
clinically applicable is vital.  The concept of structure and 
agency appears to meet this requirement and the Idea Paper  SCIENCE 
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relationship between these terms underlies many theories 
that seek to explain human behavior. 
 
Germov has defined each of these terms and has placed them 
on a continuum anchored by structure at one extreme and 
agency at the other. (Figure 1)
9 
 
He defines structure as “the recurring patterns of social 
interaction through which people are related to each other 
such as social institutions and social groups.”  Agency is “the 
ability of people, individually and collectively, to influence 
their own lives and the society in which they live.” Taken 
together, they form a useful means of explaining why people 
behave as they do. 
 
Consider for example a person who has developed Type II 
diabetes secondary to a poor diet and a lack of exercise that 
have led to obesity.  Considering this case from an agency 
perspective would mean that this individual is an 
autonomous being who chose to engage in unhealthy 
behaviors.  Their clinical condition is due to their own actions. 
 
Looking at the structural side of the case, however, would 
temper this perspective.  The social setting a person inhabits 
influences their behavior.  If they live in a neighborhood that 
does not have a grocery store with fresh fruits and 
vegetables, their dietary choices are not fully under their own 
control.  If the neighborhood is unsafe, exercising outdoors 
may be too dangerous.  Similarly, the influence of advertising 
and media that promote an unhealthy diet will also influence 
behavior and can have a negative impact on health.  
 
The relative influences of structure and agency on any 
particular human behavior have long been a source of debate 
among sociologists.
10   A strictly structural approach implies 
that people are little more than puppets on strings who are 
forced into actions due to the conditions placed upon them 
by their social groups and institutions.  An emphasis on 
agency suggests that people are autonomous actors and fully 
responsible for creating their own life-narratives.   
 
Consequently, although some social theories are derived 
primarily from either structure (e.g. Marxism) or agency (e.g. 
symbolic interactionism), theories will usually be situated 
somewhere along Germov’s continuum and not at either 
extreme.  Most theories try to combine varying degrees of 
emphasis on structure or agency.   
 
A panoply of theories with fine gradations between them 
strung along a continuum may well assist trained sociologists 
to analyze patient behaviors.  Unfortunately, it is likely to 
confuse most pharmacists who may find a more Manichean 
view of such behaviors easier to comprehend.  Accordingly, in 
this paper, the concepts of structure and agency will be 
treated as if they are strictly dualistic.  Although this is quite a 
simplistic interpretation of social theory, it makes the 
application of theory to practice more understandable to a 
practitioner with little or no training in social theories. 
 
A Clinical Example - HIV/AIDS 
Medication adherence (MA) in HIV/AIDS seems to be a 
suitable clinical example to illustrate the application of social 
theory to practice.  The consequences of poor MA are 
clinically relevant and there is a substantial literature on MA 
in this disease.   
 
In order to apply social theory to MA, it is first necessary to 
identify factors that promote or inhibit MA in patients with 
HIV/AIDS.  Qualitative studies are helpful to investigate this 
topic since qualitative methods are appropriate for studying 
the subjectively lived experiences of patients with the disease 
and their medication taking behaviors.
11-14  The studies 
described below are, with one exception, qualitative ones 
found on Medline using the MeSH terms HIV Infections, 
Qualitative Research, Patient Compliance and Medication 
Adherence.  Since this is not intended to be a systematic 
review of the MA literature in HIV/AIDS, the studies 
evaluated are intended to be only a representative sample of 
qualitative investigations of MA in HIV/AIDS in both 
developed and developing world settings.  The heterogeneity 
of the literature reviewed is actually advantageous if it can be 
shown that theory links well to practice across practice 
settings and patient populations. 
 
Barriers and Facilitators to MA 
Wilson et al. found that a person’s state of mind has an effect 
on MA.
15  In turn, context and conditions affect state of mind.  
Contextual factors included being unsure if a problem was 
caused by the drug or the disease and being confused at how 
to interpret the various medical markers of disease 
progression/regression.  If a problem is attributed to a drug, it 
will affect the person’s state of mind.  Conditions including a 
person’s self-identity, illness beliefs, their concept of time 
and the impact of the disease and medication on their 
lifestyle also influence state of mind.  A person’s beliefs about 
the disease, science and medication are likewise critical 
factors.  Since state of mind can be volatile, patient decisions 
about adherence can change quickly and MA can literally 
change dose by dose. 
 
Konkle-Parker et al. categorized both barriers and facilitators 
into factors related to the patient, environment and provider-
patient relationship.
16  Overall, barriers were found to include 
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stress, medication issues such as pill burden and side effects 
and social stigma.  Facilitators to MA were found to include 
acceptance of the diagnosis, being aware of the 
consequences of MA, prayer/spirituality and having a 
family/social support network. 
 
Wolf et al. found that low literacy was significantly related to 
MA.
17. Patients reading at below a ninth-grade level were less 
likely to know how and when to take their medication. 
 
In a small study of the lived experience of HIV/AIDS in women 
of color, Wayson -Locher et al. found that medication side 
effects, personal issues of motivation or avoidance related to 
their medication and feeling tethered to medication were all 
important factors in MA.
18  Issues of trust and belief in both 
one’s medications and one’s providers were also found to be 
important. 
 
In a study of the effects of stigma on MA in HIV/AIDS, 
Rintamaki et al. found that subjects reported concern for 
HIV/AIDS related stigmatization and that such concerns 
affected MA.
19  Stigma concerns were found to influence a 
person’s mental health, which in turn affected their 
understanding of treatment, their self-efficacy and ultimately 
MA. 
 
Studies done in the developing world reflect different patient 
populations and lived experiences of people with HIV/AIDS 
but nevertheless, barriers and facilitators to MA are often 
similar to those found in the developed world. 
 
In a study of Peruvian men with HIV/AIDS, Curioso et al. 
found a number of facilitators to MA including patient related 
factors (seeing positive results from therapy, incorporating 
medication taking into daily life), positive beliefs about 
medication (belief in the efficacy of medications, 
understanding the need for adherence), acceptable 
medication schedules (using compliance aids, having a fixed 
routine for medication taking, support and reminder systems) 
and other factors (positive relationships with health care 
providers, having a simple drug regimen).
20  Barriers to MA 
were equally diverse and included patient factors (simply 
forgetting to take pills, fear of stigma, high cost of therapy), 
negative beliefs about medication (side effects, medications 
are harmful or ineffective), difficult medication schedule 
(dietary requirements with some pills, being away from 
home, being too busy) and other factors (mistrust in 
providers, feeling healthy, feeling hopeless, pill size, 
continued substance abuse). 
 
Two studies of MA in Zambian women found that feelings of 
hopelessness inhibit MA.  Murray et al. uncovered barriers to 
MA some of which were similar to ones found in the 
developed world and some which were culturally specific.
21  
Concerns for side effects and stigma were similar to other 
studies.  However, Zambian women did not have any concept 
of what it means to have a chronic disease requiring life-long 
medication.  Other locally specific barriers included fear of 
physical harm from their husbands (who usually felt that they 
themselves were not affected by HIV/AIDS), local rumors 
about the dangers of the medications, not having adequate 
food to stave off the hunger pains caused by the medications 
and a pervasive sense of hopelessness and fatalism. 
 
Grant et al. found that Zambian women are affected by a 
variety of structural, economic, cultural and personal factors 
that influence MA.
22  A positive outlook, a social support 
system, having a reminder system for taking medication, 
goals for the future and a desire for financial independence 
were all found to be facilitators for MA.  Conversely, 
medication side effects, financial concerns and food 
insecurity were barriers to MA. 
 
Several studies in China likewise show reasonably good 
replication of findings with other research on MA barriers and 
facilitators.  Chen et al. found the strongest predictor of MA 
was an absolute faith in one’s physician. 
23 Even in the face of 
severe medication side effects that would be expected to 
result in non-adherence, patients with faith in their 
physicians were likely to remain adherent. 
 
In a study performed in Southern China, Sabin et al. identified 
several themes that affect MA.
24  Stigma was widely found to 
have the greatest impact on MA and respondents were 
greatly concerned that family members or co-workers would 
discover their HIV status if they took medication in front of 
them.  They also reported fears their co-workers would place 
a courtesy stigma against their family members.  Economic 
woes and mental health issues, primarily depression, fear of 
death, social isolation and a lack of family support were other 
barriers noted. 
 
Starks et al. studied MA in HIV positive patients in Beijing.
25  
Facilitators for MA were found to include being motivated  
(seeing positive medication results, a strong will to live, a 
peer support network and a sense of obligation to family) and 
using proximal cues to action (self-discipline in taking 
medications, use of a pill reminder box, having family 
members or partners remind them to take medication).  
Barriers were similar to studies done elsewhere and included 
stigma, access (costs, transportation problems), knowledge 
(fear of side effects, inadequate patient education about 
medications), and a lack of proximal cues to action (irregular 
schedules, difficulty taking medication when away from Idea Paper  SCIENCE 
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home).   
 
Finally, one study examined MA in the rather unique patient 
sub-group of those who were identified as 100% adherent to 
drug therapy.
26  Such complete adherence was found to be 
related to themes of drug regimen (tailoring medications to 
fit one’s lifestyle, accepting limits and tradeoffs between drug 
side effects and positive clinical response, acknowledging the 
medication’s effects in maintaining health), self (owning one’s 
problems and solutions, investing in oneself, adopting a 
realistic outlook) and the environment (recognizing and using 
a support system, identifying and using personalized tools for 
adherence, having a positive partnership with the physician).  
Since this study was in 100% adherent people, no 
investigation into barriers to MA was possible.  
 
Structure, Agency, Facilitators and Barriers 
Although the number and variety of factors that affect MA 
may appear daunting, they can be empirically stratified into 
four categories:  agency related factors that facilitate MA; 
agency related factors that are barriers to MA; structural 
factors that facilitate MA; structural factors that are barriers 
to MA.  Table 1 provides one such stratification.  Each of the 
MA factors described above (e.g. attitude or access) has been 
assigned to one of the four categories.  
 
Because studies usually identified factors as facilitating or 
inhibiting MA, assigning factors to the categories of facilitator 
or barrier was straightforward.  Assigning factors into the 
appropriate category of structure or agency was less clear-
cut.   
 
Factors were empirically assigned to the structure or agency 
categories using Germov’s definitions.
9  Those considered to 
be primarily under one’s individual control (e.g. attitudes or 
knowledge about one’s illness and medications) were 
stratified into agency categories, while factors considered to 
be primarily outside one’s individual control (e.g. access to 
care or stigma) were stratified into structural categories. 
 
Two concerns may be noted when assigning categories: (i) 
deciding if a factor clearly fits into a particular one; (ii) the 
same factor being presented in the literature from both 
positive and negative perspectives and thus reasonably fitting 
into more than one category. 
 
Deciding if a factor is clearly under a person’s control (agency 
category) or not (structural category) requires judgment and 
reasonable people may disagree.  For example, in Table 1, 
being busy is assigned to the category of agency related 
barriers under the assumption that people can choose how to 
spend their time.  Others however could consider being busy 
to be a structural barrier since time requirements for work or 
childcare may be beyond an individual’s control.   
Being faced with this quandary is less problematic that it 
appears.  As will be discussed below, agency related MA 
problems usually require a different type of pharmacist’s 
intervention than structural ones.  If one assigns a factor to a 
structural category and a structurally focused intervention 
does not solve the problem, then one may reasonably move 
that factor to the agency category and try a different kind of 
intervention when next faced with that problem. 
 
The second concern is that in some cases, assigning a factor 
to a particular category depends on how it was described in 
the literature.  Consider the example of patient-provider 
relationships.   Participants in the study by Curioso et al. 
stated they had a positive relationship with their providers 
that promoted MA while the participants in the study by 
Wayson-Locher et al. stated that a lack of trust in their 
providers had a negative impact on MA.
18,20  Consequently, 
the concept of “trust” can be placed into both the facilitator 
and barrier categories depending on the perspective used in 
the original study. 
 
Merging Theory and Practice 
Pharmacists faced with patients who have MA problems may 
often be at a loss for what to do next.  Absent any deeper 
exploration into the causes of MA and how such causes fit 
into the structure agency theory, pharmacists often can do 
little more than provide standard patient counseling advising 
patients to adhere to therapy.   
 
Similarly, pharmacy faculty who teach patient counseling for 
MA will be better able to teach students more patient specific 
patient management skills if they are aware of how MA fits 
with social theory.  They will be able to teach students how to 
identify appropriate counseling interventions depending on 
which structure or agency category various MA factors are 
assigned to. 
 
Table 1 suggests that many MA factors in HIV/AIDS are 
agency related and are both amenable to change and within 
the pharmacist’s scope of practice.  It is, however, necessary 
for a pharmacist dealing with MA problems in such patients 
to inquire more deeply into the causes of such MA in order to 
provide an appropriate clinical intervention.  A patient who 
has a sense of fatalism about their illness will require a 
different pharmacist’s intervention than one who simply 
believes they are too busy to take their medications correctly.  
Generic patient counseling and exhortations to take one’s 
medications lest a poor clinical outcome result are unlikely to 
be effective since such types of interventions may not be 
related to the underlying cause of poor MA. Idea Paper  SCIENCE 
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Structural MA problems appear to be both less common and 
more variably related to the pharmacist’s purview.  Mental 
health, economic and access related MA problems, for 
example, require a pharmacist to refer the patient to a more 
appropriate provider.   
 
Table 2 lists possible pharmacist’s interventions that would 
be expected to be beneficial according to the category.  It is 
apparent that interventions can be targeted towards specific 
MA problems once each MA factor has been appropriately 
categorized. 
 
Limitations 
Several limitations to the arguments raised in this paper may 
be identified. 
 
The literature used to link theory to practice was intended to 
be a representative sampling of the kinds of studies found in 
the MA in HIV/AIDS literature.  A systematic review may 
reveal additional and important MA factors not considered in 
this paper.  
 
As noted, assigning each MA factor into a category was done 
empirically.  A more rigorous method could have been to 
perform a content analysis on the literature cited in order to 
identify MA factors and their relationships to structure and 
agency more formally.
27  This would probably result in a 
smaller number of coherently and thematically related 
factors rather than the longer list of less precise ones 
identified here.  A smaller number of factors would be 
advantageous for pharmacists who may find that trying to 
 identify one out of a long list of possible MA factors is 
difficult and time consuming. 
 
Conclusions 
Ideally, this paper will serve as a “proof of concept” that 
social theory can be related to practice problems in such a 
way as to assist pharmacists in providing high quality patient 
care services.  
 
Additional work is required in several areas.  Can different 
social theories be employed similarly to the way that 
structure and agency theory was used in this paper?  Are 
problems other than MA or diseases other than HIV/AIDS 
suitable clinical problems that are also addressable by linking 
theory and practice?  Pending such confirmatory work 
however, there does appear to be a link between social 
theory and practice that would be of help to pharmacists 
providing patient care. 
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Agency Related 
Facilitators 
Agency Related Barriers  Structural Facilitators  Structural Barriers 
Manageable medication 
regimen/Belief 
medications work/Low 
pill burden/Few side 
effects 
Low literacy  Adequate social support 
system/Having another 
to live for 
Feelings of stigma/Lack 
of confidentiality/ Lack 
of trust in medications 
or providers 
Positive but realistic 
attitude/Motivation to 
live and succeed 
Loss of hope/Fatalism  Good efficacy of 
medications 
Mental health 
problems 
Use of reminders, 
adherence aids/Cues to 
action 
Denial/Feeling 
healthy/Uncertainty 
about disease or 
treatment/Ideology or 
belief system 
  Economic problems 
Positive partnership with 
providers 
Fear of domestic 
violence/Abuse 
  Poor access to care 
Adequate knowledge of 
disease, medications, 
side effect management, 
need for adherence 
No cultural framework 
for chronic illness or 
medication use 
  Food 
insecurity/Prescribed 
dietary changes 
Making taking 
medications a routine 
activity 
Feeling one is too 
busy/Simply 
forgetting/Heavy 
planning burden 
   
Prayer/Spirituality  Continued substance 
abuse 
   
Good self-efficacy  Belief that medications 
are harmful/Fear of side 
effects/High pill 
burden/Complex 
medication regimen 
   
 
Table 1 – Agency and Structural Factors That Facilitate or Inhibit Medication Adherence 
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Interventions to maintain agency 
related facilitators 
  Design medication regimens with few side effects, low pill 
burden 
  Provide patient education on disease, medication, side 
effects, need for MA 
  Provide positive reinforcement on medication efficacy and 
safety 
  Provide motivation for MA.  Maintain patient self-efficacy 
on MA.  
  Be empathetic and develop partnership with patient 
  Provide MA aids and cues to action.  Design medication 
regimens around patient’s lifestyle 
  Encourage patient’s faith and spirituality when appropriate 
Interventions to improve agency 
related barriers 
  Provide or refer to training program in health literacy 
  Provide emotional support or referral to expert for loss of 
hope, denial, cultural practices or belief systems that 
impair MA 
  Referral to domestic abuse support services 
  Provide MA aids and cues to action.  Design medication 
regimens around patient’s lifestyle 
  Refer to substance abuse program 
  Provide positive reinforcement on medication efficacy and 
safety 
Interventions to maintain 
structure related facilitators 
  Refer to social services  
  Design optimally efficacious drug regimen 
Interventions to improve 
structure related barriers 
  Be empathetic and develop partnership with patient.  
Promote trust and confidentiality in patient relationship. 
  Refer to mental health services 
  Refer to social services 
  Refer to nutrition services 
 
Table 2 – Possible Pharmacist’s Interventions According to MA Factors 
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